The Personalized Medicine Coalition (PMC) is pleased today to welcome Congressman John Moolenaar (R-MI-02) as a new co-chair of the Congressional Personalized Medicine Caucus. In a bipartisan show of support for the caucus and personalized medicine, Rep. Moolenaar agreed to join Eric Swalwell (D-CA-14) as a second House co-chair. Kyrsten Sinema (I-AZ) and Tim Scott (R-SC) are the co-chairs of the caucus in the Senate.

Launched in 2020 by Reps. Swalwell and Tom Emmer (R-MN-06) and Sens. Sinema and Scott, the Congressional Personalized Medicine Caucus is a bipartisan, bicameral platform that aims to educate Members of Congress and their staff on the unprecedented opportunities personalized medicine presents to help physicians detect the onset of disease at its earliest stages, pre-empt disease progression, and improve the quality, accessibility, and affordability of health care in the United States. The caucus works on legislation to advance the utilization of advanced diagnostic tests that can identify disease markers at the molecular level and help predict the likelihood of patient response to certain therapies. It also works to encourage the development of targeted therapies that can make treatment more efficient and effective.

“The American people want health care solutions that are tailored to meet their needs,” said Moolenaar. “As the new co-chair of the Congressional Personalized Medicine Caucus, I look forward to working with my colleagues on truly bipartisan ideas that will make life better for Americans. American innovation in health care is helping patients every day and I will focus on how we can strengthen our supply chains and develop new treatments that will help Americans enjoy longer, healthier lives with their loved ones.”

“At a moment when rapidly emerging biomedical breakthroughs are delivering unprecedented insights about the molecular underpinnings of human health and disease, promising better outcomes and greater efficiencies, PMC is pleased to welcome Rep. Moolenaar as a co-chair of the Congressional Personalized Medicine Caucus,” said PMC President Edward Abrahams. “Through their educational and legislative activities, Rep. Moolenaar and the other caucus Members can play a key role to ensure that the United States health system takes full advantage of every opportunity to make American patients healthier.”